Abnormalities in Copper Status Associated with an Elevated Risk of Parkinson's Phenotype Development

Area of Science:

• Neuroscience
• Biochemistry
• Genetics

Background:

• Parkinson's disease (PD) is increasingly recognized as a potential copper-mediated disorder.
• Over 640 studies have explored the link between PD and various blood copper markers, including total copper, ceruloplasmin (Cp) concentration, Cp protein levels, and non-ceruloplasmin copper.
• The precise correlation between copper status and PD development remains debated due to varied methodologies, often focusing on single markers.

Purpose of the Study:

• To investigate the connection between copper imbalance and the risk of developing idiopathic Parkinson's disease.
• To explore the role of specific copper-related genetic disorders in PD pathogenesis.
• To clarify the relationship between circulating and cerebrospinal fluid ceruloplasmin levels and PD.

Main Methods:

• Literature review and meta-analysis of published research on copper and PD.
• Analysis of own research data correlating copper status with PD.
• Discussion of inborn errors of copper metabolism impacting ceruloplasmin levels.

Main Results:

• A clear association exists between PD symptoms and the quantity of copper atoms weakly bound to ceruloplasmin.
• Inborn errors of copper metabolism, leading to reduced ceruloplasmin (Cp) levels, are linked to an increased risk of developing PD.
• Decreased ceruloplasmin oxidase levels in circulation and cerebrospinal fluid are implicated in PD risk.

Conclusions:

• Copper metabolism plays a significant role in the pathogenesis of Parkinson's disease.
• Altered copper binding to ceruloplasmin is a key factor in PD development.
• Further research into copper metabolism disorders is crucial for understanding and potentially treating PD.